Sign in

CIK 0000318306

  • Non-accelerated filer
  • Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
830221517
Phone
+1 646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 11,044 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Shares withheld for taxes Chief Financial Officer gave up 1,055 shares (to pay taxes)
  5. 4 Grant or award Director acquired 23,611 shares (grant or award)
  6. 4 Grant or award SVP, General Counsel acquired 102,689 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 155,200 shares (grant or award)
  8. 4 Grant or award Director acquired 23,611 shares (grant or award)
  9. 4 Grant or award Director acquired 23,611 shares (grant or award)
  10. 4 Grant or award Director acquired 23,611 shares (grant or award)
  11. 4 Grant or award Director acquired 23,611 shares (grant or award)
  12. 4 Grant or award Director acquired 23,611 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 424,000 shares (grant or award)
  14. 4 Open-market sale Director sold 25,890 shares at $4.51 ($116,764)
  15. 4 Open-market sale Director sold 25,821 shares at $4.51 ($116,453)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 16,408 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 38,621 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, General Counsel gave up 10,951 shares (to pay taxes)
  19. 4 Shares withheld for taxes SVP, General Counsel gave up 92 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 703 shares (to pay taxes)

Page 6 of 20 · 394 filings